Antilipolytic drugs for the prevention of primary ventricular fibrillation

Diabetes, Obesity and Metabolism

Volumn 3, Issue 2, 2001, Pages 61-65

  Oliver, Michael F ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b Keepier Wharf   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; ALBUMIN; APOLIPOPROTEIN C2; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARNITINE PALMITOYLTRANSFERASE; CATECHOLAMINE; ENZYME INHIBITOR; FATTY ACID; GLUCOSE; GLYCOGEN; INSULIN; LIPOPROTEIN LIPASE; NICOTINIC ACID DERIVATIVE; NORADRENALIN; OXYGEN; PIPERAZINE DERIVATIVE; POTASSIUM; RANOLAZINE; TRIMETAZIDINE;

CLINICAL TRIAL; DIABETES MELLITUS; FATTY ACID OXIDATION; GLUCOSE OXIDATION; GLUCOSE TRANSPORT; GLYCOLYSIS; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART VENTRICLE FIBRILLATION; HUMAN; LIPOLYSIS; MORTALITY; OXYGEN CONSUMPTION; REVIEW;

EID: 0034877172     PISSN: 14628902     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1326.2001.00147.x     Document Type: Review

References (32)

1. Metabolic derangement in ischemic heart disease and its therapeutic control
2. Modulation of responses to myocardial ischemia: Metabolic features of myocardial stunning, hibernation, and ischemic preconditioning
3. A decade of clinical trials: CAST to AVID
4. Electropharmacological control of cardiac arrhythmias: To delay conduction or to prolong refractoriness
5. Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction
6. Initial metabolic and hormonal response to acute myocardial infarction
7. Serum-free-fatty-acids after acute myocardial infarction and cerebral vascular occlusion
8. Metabolic responses of the heart in acute myocardial infarction in man
9. Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction
10. Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction
11. Essential fuels for the heart and mechanical restitution
12. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias
13. Effect of free fatty acids on myocardial functions and oxygen consumption in intact dogs
14. Optimizing cardiac energy metabolism: A new approach to treating ischaemic heart disease
15. Relation between serum free fatty acids and arrhythmias and death after acute myocardial infarction
16. The transport and utilization of free fatty acid
17. The role of free fatty acids in the production of ventricular arrhythmias after acute coronary artery occlusion
18. A metabolic cause for arrhythmias during acute myocardial hypoxia
19. Arrhythmias following infusions of fatty acids
20. Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey
21. Prevention of sudden cardiac death by dietary pure β-3 polyunsaturated fatty acids in dogs
22. Metabolic approaches in ischaemic heart disease
23. Control of ventricular arrhythmias during myocardial infarction by antilipolytic treatment using a nicotinic acid analogue
24. Effect of inhibition of lipolysis on infarct size after experimental coronary artery occlusion
25. Anti-lipolytic therapy in angina pectoris: Reduction of exercise-induced ST segment depression
26. β-blockade after myocardial infarction: Systematic review and meta regression analysis
27. Effects of ranolazine on ischemic threshold, coronary sinus blood flow and myocardial metabolism in coronary artery disease
28. Lipoprotein and hepatic lipase in lipoprotein metabolism
29. Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism
30. Metabolic modulation of acute myocardial infarction: The ECLA Glucose-Insulin-Potassium pilot trial
31. Effects of glucose-insulin-potassium on myocardial substrate availability and utilisation in stable coronary artery disease
32. For the DIGAMI group: Prospective randomised study of intensive insulin treatment on long-term survival after acute myocardial infarction in patients with diabetes mellitus